Abstracts

STATEWIDE TRENDS OF TRANSMITTED HIV-1 DRUG RESISTANCE IN RHODE ISLAND OVER 2004-2020

HIV-1 transmitted drug resistance (TDR) remains a roadblock toward ending the HIV epidemic due to its ability to compromise effectiveness of antiretrovirals for prevention and care. Country- and state-wide TDR data beyond selected surveillance and research efforts are absent, and available estimates are heterogenous. We aggregated [i]all[/i] available HIV-1 [i]pol[/i] partial sequences from treatment-naïve persons…

IMPACT OF NASH ON THE SURVIVAL OF PEOPLE LIVING WITH HIV

Non-alcoholic fatty liver disease (NAFLD) is an increasing concern for PLWH. However, information on the impact of NAFLD on the prognosis of PLWH is lacking. Because of these, we investigated the influence of non-alcoholic steatohepatitis (NASH) on the overall mortality in PLWH. PLWH followed in three Spanish centers were included in a prospective cohort at…

NONINVASIVE PREDICTION OF HEPATIC DECOMPENSATION IN PATIENTS WITH HIV

People with HIV (PWH) are at high risk for compensated advanced chronic liver disease (cACLD) and hepatic decompensation. While non-invasive tools (NITs) such as liver stiffness measurement (LSM) by transient elastography are used to identify those at risk of hepatic decompensation, these remain not validated and potentially inaccurate in the setting of non-cirrhotic portal hypertension…

NAFLD IS COMMON AND ASSOCIATED WITH CARDIOVASCULAR RISK IN REPRIEVE PARTICIPANTS

Non-alcoholic fatty liver disease (NAFLD) is a common problem in persons with HIV (PWH). NAFLD is associated elevated cardiovascular disease (CVD) risk. We present baseline data on the prevalence and cardiometabolic characteristics of NAFLD among REPRIEVE participants who underwent Computed Tomography (CT). The REPRIEVE Mechanistic substudy is embedded within an international primary CVD prevention RCT…

FROM NAFLD TO MAFLD: IMPLICATIONS OF CHANGE IN TERMINOLOGY IN PWH

Metabolic associated fatty liver disease (MAFLD) has been recently proposed as a new concept to describe nonalcoholic fatty liver disease (NAFLD), based on positive diagnostic criteria rather than exclusionary ones. The ongoing debate regarding NAFLD/MAFLD construct has not yet reached HIV arena. Our objective was to characterize MAFLD in comparison to NAFLD and to determine…